Marijuana Rescheduling: Why Opponents Have No Idea What They Are Talking About

By Jason Adelstone Apr 29, 2024 After listening to the House Oversight and Accountability Committee Hearing with the Commissioner of the FDA on April 11, one conclusion was reinforced—opponents of marijuana reform are misinformed and rely on misstating facts to support their position. Those against moving marijuana into schedule III are making their voices heard, but almost universally, […]